parasite, pathogens

Administrative announcements

  • Homework due Sunday at midnight; reminder sent over the holiday weekend; plan to set aside time to work on it so you don’t have too much to do.

  • iClicker grades can be confusing if you look in the iClicker app because the instructor’s account has three sections in one.

    • In iClicker, you may see zeros for questions from sections you didn’t participate in; Canvas will have the correct grade after syncing.

  • Today after this class around 11:00, the teaching assistant and the instructor will sync grades into Canvas.

    • In Canvas, you’ll see the correct grade (e.g., 4 out of 4 for that day).

    • In iClicker, the app may show, e.g., 4 out of 12 because it aggregates three sections; don’t rely on iClicker for the final grade.

  • The grade that matters is the Canvas grade after transfer.

  • If you miss a question in iClicker (don’t click in time or bathroom break), you still get a point in iClicker; the grade can be adjusted in Canvas after it’s posted there.

  • Do not email about iClicker issues; it’s easier to fix in person either before or after class because the instructor cannot easily change grades on a phone due to the Okta login and Canvas limitations.

  • You must wait until your grade is in Canvas before asking for a fix; the iClicker app cannot be the source of truth for grading.

  • Now starting the main topic: parasites and pathogens, with definitions, examples, and terminology.

The biological definitions: parasite, pathogen, ecto-/endo- and examples

  • A parasite is an organism that lives on or in a host and typically derives benefit at the host’s detriment; the host suffers a negative impact while the parasite gains benefit.

  • A pathogen is a microorganism that can cause disease; from a strict biological standpoint, all pathogens are parasites.

  • In common medical language vs. biological language there can be overlap and informal differences in usage.

  • Prefixes:

    • ecto-\text{ecto-} means outside (lives on the outside of the body; example: toe fungus / athlete’s foot).

    • endo-\text{endo-} means inside (an endoparasite is inside the body; example: certain worms).

  • Examples:

    • Ectoparasite: toe fungus described as living on the outside of the body (athlete’s foot).

    • Endoparasite: a worm that lives inside the body (filariasis/elephantiasis) blocking the lymphatic system and causing edema.

  • Treatments by type:

    • Antiparasitic medicines for parasites (e.g., worms).

    • Antifungal creams for fungal infections (e.g., athlete’s foot are common and sold in grocery stores).

  • Microbes thrive in warm, moist environments with dead skin available for nutrients; athlete’s foot can crack and scab if severe.

  • Key notes on terminology:

    • In medicine, the terms pathogen and parasite can be used differently in informal language; however, in a strict biological sense, pathogens are a subset of parasites.

  • Other major parasite/pathogen groups used in medicine:

    • Protists (single-celled eukaryotes with a nucleus): malaria (Plasmodium falciparum), giardiasis, trichomoniasis, etc.

    • Worms (multicellular parasites).

    • Mites (ectoparasites).

  • Associated disease and pathogen examples:

    • Malaria (protozoan parasite).

    • Urinary tract infections often involve pathogenic E. coli (a bacterium) that may require specific adhesion mechanisms (e.g., p pili) to attach to urogenital epithelial cells.

  • Distinction between pathogen types in medicine:

    • Pathogen: organisms that cause disease (bacteria, fungi, viruses, parasites).

    • In medical publications, pathogens and parasites are named and grouped with varying emphasis; colloquial use can differ from formal usage.

Pathogenicity and virulence: key concepts and metrics

  • Pathogenicity: the ability of an organism to cause disease.

    • Example: E. coli strains that are pathogenic have specific genes (e.g., adhesion factors) enabling them to cause urinary tract infections.

  • Pathogenic vs non-pathogenic strains:

    • Many E. coli strains are commensal in the colon and do not cause disease; pathogenic strains carry extra genes that enable disease.

  • Primary pathogens vs opportunistic pathogens:

    • Primary pathogens cause disease in a healthy host (e.g., Ebola).

    • Opportunistic pathogens cause disease when normal defenses are compromised (e.g., Candida albicans in antibiotic-treated individuals, Staphylococcus aureus in a wound).

  • Significance of infection types:

    • Acute infections: rapid onset and resolution (e.g., acute influenza).

    • Chronic infections: long-lasting with latent periods; example: herpes simplex virus type 1 (HSV-1) causing cold sores with latency in the trigeminal nerve; can reactivate under stress or immune suppression.

    • Examples of latency and reactivation: chickenpox (varicella) causing shingles (herpes zoster) later in life; long-term virus persistence in nervous tissue.

  • Immunocompromised conditions:

    • Pneumocystis jirovecii pneumonia is an opportunistic infection common in AIDS patients.

  • HIV/AIDS link:

    • HIV is the etiologic agent of AIDS; AIDS is a syndrome with characteristic opportunistic infections such as Kaposi’s sarcoma and Pneumocystis pneumonia.

  • Signs that reflect disease rather than mere infection:

    • Signs: objective measurements (e.g., fever, rash, high blood pressure).

    • Symptoms: subjective experiences reported by the patient (e.g., fatigue, pain).

  • Syndromes:

    • A syndrome is a constellation of signs and symptoms that often accompany a disease (e.g., AIDS is a syndrome with specific opportunistic infections).

    • HIV causes AIDS; SARS-CoV-2 virus causes the disease COVID-19.

  • Immunopathology:

    • Some disease manifestations are caused by the host immune response (fever, inflammation) rather than direct pathogen damage.

    • Immunopathology can also contribute to tissue damage during infection.

  • Long-term sequelae and long-term symptoms:

    • Long COVID: persistent symptoms after initial infection; variable organ involvement, including pulmonary, neurological, and other system damage.

  • Invasiveness and tissue spread (virulence factors):

    • Invasiveness refers to the ability of a pathogen to invade tissues and disseminate (e.g., Salmonella invading intestinal cells and disseminating via lymphatics and bloodstream).

    • The lysosome is the cellular organelle that fuses with endocytic vesicles to digest pathogens; some pathogens block fusion to survive inside cells.

  • Epidemiology and dose concepts:

    • Infectious dose 50 (ID_{50}): the number of organisms needed to infect 50% of hosts.

    • Lethal dose 50 (LD_{50}): the number of organisms needed to kill 50% of hosts.

    • Example narrative: If we give each of 4 people 75 cells of Mycobacterium tuberculosis, and 50% become infected, that dose corresponds to ID_{50} = 75.

    • In contrast, if 400 cells kill 50% of hosts, then LD_{50} = 400.

    • Infections can occur with doses below ID{50} if the host immune system is strong; exposure above ID{50} increases infection probability.

  • Practical notes on ID{50} and LD{50}:

    • These measurements are typically obtained in animal models (not humans) due to ethical constraints.

    • The graph of virulence often plots dose (x-axis) versus response (infection or death) (y-axis).

    • The infectious dose and lethal dose can vary by strain and host species and across different exposure routes.

    • Real-world exposure may involve multiple routes and presences of vaccines or prior immunity that alter effective ID{50} or LD{50}.

  • Historical and ethical context:

    • Human experimentation without consent has occurred in the past; informed consent is now required for clinical trials.

    • Animal testing is used to assess safety and efficacy; legal and ethical frameworks govern how data are translated to humans.

  • Public health relevance:

    • Public health agencies track ID-like and LD-like concepts when modeling outbreaks and assessing risk.

    • Vaccinations and prior immunity can reduce effective infection and mortality burden in populations.

Invasiveness, host range, and examples of pathogenic spread

  • Invasiveness:

    • The ability of a pathogen to invade tissues and spread within a host; some organisms remain localized, others disseminate systemically.

    • Example: Salmonella invades intestinal cells; it can block lysosome fusion, enter macrophages, travel via lymph nodes and bloodstream, and cause systemic infection.

  • Host range:

    • Host range is the number of species a microbe can infect.

    • HIV has a narrow host range (humans only).

    • SARS-CoV-2 has a broader host range (humans and many mammals; original reservoir identified as bats; spread to deer and other species).

  • Transmission modes and reservoirs:

    • Direct contact and vehicle transmission (airborne, water, contaminated surfaces).

    • Fomites: inanimate objects that harbor pathogens (e.g., door handles, beds, medical instruments).

    • Parenteral route: infections introduced directly into the bloodstream via needles (e.g., intravenous drug use); sterile technique and safe injection practices are critical.

    • Vertical transmission: mom-to-child transmission during childbirth or transplacentally; transplacental infection examples (syphilis can affect the baby, causing congenital disease).

    • Horizontal transmission: person-to-person or animal-to-human transmission (most routes are horizontal).

    • Arthropod vectors: living organisms that harbor and transmit pathogens (biological vectors) or simply carry them mechanically (mechanical vectors).

  • Fomites and infection control:

    • Fomites are a major vector in healthcare settings (e.g., door handles, patient beds, equipment).

    • Antimicrobial materials (e.g., silver or copper threads) can reduce microbial survival on surfaces and fabrics.

  • Vectors: biological vs mechanical:

    • Biological vectors: the pathogen’s life cycle includes an intermediate host (e.g., ticks carrying Rickettsia rickettsii — RMSF; malaria parasites in mosquitoes).

    • Mechanical vectors: vectors carry pathogens on their bodies without hosting the pathogen’s life cycle (e.g., a fly carrying pathogens on its legs from feces to food).

  • Zoonoses and reservoirs:

    • Zoonotic diseases involve animal reservoirs or vectors (e.g., Lyme disease with deer as reservoir, ticks as vectors; Ebola with bats and primates; SARS-CoV-2 linked to bats initially and later found in other mammals).

    • Reservoirs can be asymptomatic or symptomatic; some pathogens persist in animal reservoirs and repeatedly spill over to humans.

  • Case study ideas and examples:

    • Bubonic plague: Yersinia pestis; 1884 Chinese outbreak; buboes (enlarged lymph nodes) are characteristic; primary reservoir rats; flea vector; historical context includes the European Black Death.

    • Lyme disease: Borrelia burgdorferi; deer are reservoir; deer ticks transmit to humans; geographic distribution influenced by deer/tick populations.

    • Rocky Mountain spotted fever: RMSF; transmission by ticks; fever and rash as clinical signs.

    • Respiratory pathogens and vaccine history: polio eradication efforts and vaccination campaigns; measles outbreaks in areas with reduced vaccination coverage; public health strategies rely on vaccination campaigns and surveillance.

Signs, symptoms, disease, and syndromes

  • Signs vs. symptoms:

    • Signs are objective, measurable abnormalities (e.g., fever, rash, high blood pressure).

    • Symptoms are subjective experiences reported by the patient (e.g., fatigue, pain).

  • Disease vs infectious disease:

    • A disease is a condition involving a dysfunction of body systems with signs and symptoms.

    • An infectious disease is a disease caused by a pathogen that can be spread to others.

  • Syndromes:

    • A syndrome is a collection of signs and symptoms that may be caused by more than one disease (e.g., AIDS as a syndrome with opportunistic infections).

  • Case example: syphilis case study (from early chapter):

    • Primary sign: a genital lesion (chancre) that is painless and may leak fluid; a sign because it’s observable.

    • Symptom: patient reports no pain at the lesion; this helps differentiate syphilis from other STIs with painful lesions.

  • Immunopathology and long-term symptoms:

    • Some symptoms arise from the host immune response (fever and inflammation) rather than direct pathogen damage.

    • Long-term sequelae can include organ damage (e.g., heart or nervous system) after an infection like strep throat leading to rheumatic fever or other complications; long COVID is an example of chronic symptoms after infection.

  • Infections’ five phases (time course):

    • Incubation period: time between exposure and onset of replication; patient may be asymptomatic.

    • Prodromal phase: early nonspecific symptoms; immune system begins to respond.

    • Acute phase: classic signs and symptoms prominent; pathogen replicates; symptoms are noticeable.

    • Decline phase: symptoms begin to improve as the immune system and/or treatment reduces pathogen burden.

    • Convalescent/ Chronic phase: recovery or chronic/latent infection depending on pathogen.

  • Long-term effects and chronic infections:

    • Examples include prolonged lung damage after severe respiratory infections; neuropathies or chronic fatigue after certain viral infections; long-term complications after streptococcal infections affecting the heart (rheumatic fever) in some histories.

  • Zoonotic disease and public health relevance:

    • Infectious disease surveillance relies on documentation of notifiable diseases to monitor outbreaks and inform public health responses.

Public health surveillance, reporting, and epidemiology

  • CDC and notifiable diseases:

    • Morbidity (incidence of disease) and mortality (deaths) statistics are tracked; the CDC provides an ongoing Morbidity and Mortality Weekly Report (MMWR).

    • Notifiable diseases must be reported by clinicians and laboratories to local health departments, which then report to the state health department and the CDC.

    • The CDC aggregates data to inform national and international surveillance (WHO) and to guide public health actions.

  • Local disease tracking example:

    • Clinicians may assess regional disease incidence (e.g., syphilis) by city and week; data may be organized by disease in modern systems.

  • Practical public health implications:

    • Outbreak detection and response depend on timely reporting and data collection to identify clusters and implement interventions.

    • Public health data support diagnosis, vaccination strategies, and outbreak containment.

  • Case example: a college student case and tick-borne disease:

    • Patient history is crucial for diagnosis (recent travel, exposure to ticks, camping in North Carolina).

    • Rocky Mountain spotted fever was considered when a tick bite exposure was reported; not all exposed individuals become ill, illustrating variable host response.

Transmission, vectors, and disease ecology

  • Modes of transmission (summary):

    • Direct contact (person-to-person via touch, droplets).

    • Vehicle transmission (airborne, water, food, fomites via environment).

    • Vector-borne transmission (biological vectors with a pathogen; mechanical vectors that carry pathogens on their bodies).

  • Fomites (inanimate objects):

    • Examples include surfaces, door handles, surgical tools, bed rails; significant in healthcare settings.

    • Countermeasures: disinfection, sterilization, and using antimicrobial materials (e.g., silver threads) can reduce transmission.

  • Vertical vs horizontal transmission:

    • Vertical: mother to baby (transplacental or perinatal during childbirth).

    • Horizontal: all other modes of transmission (person-to-person, animal-to-human, etc.).

  • Transplacental transmission:

    • A mechanism for some pathogens to reach the fetus; can cause congenital infections (e.g., syphilis).

  • Parenteral route and injection safety:

    • Parenteral portal of entry refers to direct entry of pathogens into the bloodstream (e.g., via needles).

    • Safe injection practices are essential in clinical settings to prevent iatrogenic infections.

  • Arthropod vectors and reservoirs:

    • Biological vectors: pathogens complete part of their life cycle in the vector (e.g., ticks transmitting RMSF).

    • Mechanical vectors: pathogens are carried on the vector’s body without replication in the vector (e.g., a fly transferring pathogens on its legs).

    • Animal reservoirs can be asymptomatic or symptomatic and serve as sources for spillover to humans (e.g., deer for Lyme disease; bats and primates for Ebola).

  • Zoonosis and reservoir concepts:

    • Zoonotic diseases originate in animals and can be transmitted to humans (zoo + notos: animals).

    • Reservoir species maintain the pathogen in nature; spillover to humans can occur under ecological or behavioral changes.

Biosafety, lab safety levels, and standard precautions

  • Biosafety levels (BSL) overview:

    • BSL-1: Basic microbiology, non-pathogenic organisms; minimal precautions.

    • BSL-2: Work with human pathogens that pose moderate hazards; requires PPE, biosafety cabinet (BSC) for certain procedures; example: the on-campus BSL-2 lab.

    • BSL-3: Pathogens that can be inhaled and cause serious illness; requires specialized facilities, containment, and PPE; not in the provided campus lab.

    • BSL-4: Highest containment for exotic, deadly, untreatable pathogens (e.g., smallpox, Ebola); requires space suits and highly controlled entry/exit protocols; only a small number of labs exist worldwide.

  • Laboratory practices and equipment:

    • Biosafety cabinets (BSC) protect both the worker and the environment; they maintain airflow and filter pathogens; some cabinets use filters with 0.2-micron HEPA filters; some cabinets include antimicrobial filters (e.g., silver threads) for added protection.

    • Proper sterilization and disinfection protocols are essential; many instruments and surfaces require cleaning and disinfection between uses.

    • PPE: gloves, lab coats, eye protection, respirators as required by the risk level.

  • Universal and standard precautions:

    • Treat all body fluids as potentially infectious; assume the possibility of asymptomatic infection (e.g., TB can be asymptomatic in about 10% of cases).

    • Respiratory hygiene/cough etiquette; safe injection practices; handling sharps safety; patient isolation when contagious; proper sterilization/disinfection.

  • Practical notes on lab training:

    • Institutions may have limited spaces for student laboratory work due to biosafety constraints.

    • Students in microbiology majors typically learn lab safety and pathogen handling, with strict adherence to BSL guidelines.

  • Ethical and public health considerations:

    • Historical context of human experimentation without consent informs current ethics and informed consent requirements for clinical trials.

    • Public health surveillance depends on safe, ethical lab practices and transparent reporting.

Five-phase infection timeline and clinical implications

  • Incubation period: time from initial exposure to the onset of pathogen replication and symptoms; varies by pathogen (e.g., HIV has a long incubation period).

  • Prodromal phase: early, nonspecific symptoms before the disease fully manifests.

  • Acute phase: classic signs and symptoms; high pathogen activity; clinical management often critical.

  • Decline: symptoms abate; pathogen load decreases; patient begins to recover.

  • Convalescence: recovery; signs and symptoms disappear; some pathogens may persist in latent form (latency) or cause long-term sequelae (e.g., long COVID).

  • Long-term consequences and sequelae:

    • Some infections cause lasting damage to organs (e.g., lungs after severe infections; nervous system involvement).

    • Latent infections can reactivate later (e.g., herpesviruses).

Quick reference: key terms recap

  • Infectious disease: disease caused by a pathogen that can be transmitted to others.

  • Sign: objective measurement (fever, rash, abnormal vitals).

  • Symptom: subjective experience reported by the patient (pain, fatigue).

  • Syndrome: collection of signs and symptoms that may reflect more than one disease.

  • Portal of entry: any site where a pathogen can enter the body (eyes, ears, nose, mouth, urogenital tract, skin breaches).

  • Parenteral route/portal: entry through injections or breaches in the skin.

  • Parenteral precautions: sterile technique, safe injection practices.

  • Portal of entry vs. portal of exit: entry is how the pathogen enters; exit is how it leaves the host (e.g., coughing, diarrhea).

  • Vector (biological vs mechanical): an organism that transmits a pathogen (biological includes pathogen life cycle within the vector; mechanical is incidental carriage on the vector).

  • Fomite: an inanimate object that harbors a pathogen.

  • Endemic: a disease that is always present in a population or region.

  • Epidemic: rapid increase of disease in a population or region.

  • Pandemic: disease outbreak spanning multiple countries or continents.

  • Zoonotic disease: disease that can be transmitted from animals to humans.

  • Virulence: the degree to which a pathogen can cause disease; includes infectious dose (ID{50}) and lethal dose (LD{50}).

  • ID_{50}: the dose of pathogen needed to infect 50% of hosts.

  • LD_{50}: the dose of pathogen needed to kill 50% of hosts.

  • Host range: number of species a pathogen can infect.

  • Immunopathology: disease symptoms caused by host immune response rather than direct pathogen damage.

  • Latency: period where a pathogen persists in the host with no symptoms, potentially reactivating later.

  • Notifiable diseases: infections that must be reported to local and national health authorities to enable surveillance and intervention.

Final practical takeaways

  • Always rely on Canvas for final grades after grade syncing; iClicker may display misleading totals due to multi-section settings.

  • When studying pathogens, focus on the vocab: signs vs symptoms, disease vs infectious disease, syndrome, virulence (ID{50}, LD{50}), invasiveness, host range, transmission modes, vectors, fomites, vertical vs horizontal transmission, and biosafety levels.

  • Public health context matters: surveillance, reporting chains, and outbreak response depend on accurate data collection and transmission knowledge.

  • Remember common real-world examples tied to these terms: Lyme disease (deer reservoir, tick vector), RMSF (tick-borne), bubonic plague (Yersinia pestis, rats, fleas), syphilis (chancre), herpesviruses (latency and reactivation), malaria (Plasmodium), SARS-CoV-2 (bat origin, broad host range), and long-term issues like long COVID.

// End of notes